Embryology Certificate Course
ACTIVITY NUMBER:
LABCC100C
ACTIVITY TITLE: Assisted Reproductive Technology Procedures: Basic Course
ACCREDITATION STATEMENT
The American Society for Reproductive Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The American Society for Reproductive Medicine designates this enduring material for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The American Society for Reproductive Medicine has been approved to provide Professional Enrichment Education Renewal (PEER) credit through the American Board of Bioanalysis. This activity has been approved for 7.75 PEER credits through the American Board of Bioanalysis.
Release Date: October 15, 2014
Reviewed and Updated in 2017
Expiration Date: December 30, 2025
Estimated Time to Complete Activity: 7.75 hours
NEEDS ASSESSMENT and IDENTIFICATION OF PRACTICE GAP
Discussion and evidence about reproductive laboratory technologies can be found not only in the scientific literature, but in the popular press and on the Internet as well. New technologies with implications for the treatment of the infertile couple are being developed and advancing rapidly such that even experienced embryologists might benefit from additional educational opportunities. It is important, therefore, that clinicians, laboratory scientists, and allied health professionals are aware of the basic evaluation and treatment during an IVF cycle, as well as progress in technology that may have an impact on IVF now or in the future. This online course provides detailed content in the field of basic ART laboratory techniques. This area has been identified as a practice gap for reproductive care clinicians and scientists based on recent competence assessments by the American Society for Reproductive Medicine.
EDUCATIONAL OBJECTIVES
At the conclusion of this educational activity, participants should be able to:
1. Discuss the various controlled ovarian stimulation protocols for in vitro fertilization (IVF).
2. Describe the physiologic basis for formulation of embryo culture media and aspects that may impact embryo development.
3. Discuss the role of commercially prepared culture media, in-house prepared culture media, and supplements in embryo metabolism.
4. Identify sources of culture media contamination and processes to reduce and manage contamination.
5. List the steps in oocyte retrieval for the embryologist and describe how equipment and personnel may impact the quality of the oocytes retrieved.
6. Describe the process of ejaculation and identify correct and incorrect methods of semen collection.
7. Discuss the sperm preparation for assisted reproduction, including media and supplements, swim-up and density gradients, testicular and epididymal sperm, and fresh versus frozen sperm.
8. Discuss methods of oocyte insemination including conventional and intracytoplasmic sperm injection (ICSI) and describe oocyte handling including cumulus removal, maturation assessment, and injection methods for ICSI.
9. List the steps to prepare oocytes for fertilization assessment, evaluate signs of normal fertilization and identify indicators of fertilization quality and abnormal fertilization.
10. Discuss the normal developmental kinetics of human embryos from day 1 through day 3, the morphological features that are typically used in assessment, and identify morphological predictors of embryo viability.
11. Describe the process of blastocyst selection and grading including evaluation of the inner cell mass and trophectoderm cells, and discuss the role of blastocyst transfer.
12. Describe the role of the embryologist in the embryo transfer process and discuss the factors that may affect the success of embryo transfer.
13. Define third-party reproduction, the recommended screening, informed consent, compensation and cycle synchronization for oocyte donors and therapeutic donor insemination, and identify the guidelines for embryo donation and surrogacy.
COURSE OUTLINE
Assisted Reproductive Technology Procedures – Basic
1. Stimulation Protocols
2. Culture Media and Conditions, Part 1
3. Culture Media and Conditions, Part 2
4. Microbial Contamination of IVF Cultures
5. Oocyte Retrieval
6. Semen Collection
7. Sperm Preparation
8. IVF Insemination
9. Changeover Day Fertilization Assessment
10. Cleavage-Stage Embryo Grading
11. Blastocyst Development and Grading
12. Embryo transfer
13. Third-party Reproduction
TARGET AUDIENCE
This activity is designed to meet the educational needs of new and experienced clinicians, laboratory scientists and allied health professionals with an interest in ART laboratory technologies for the evaluation and treatment of the infertile couple.
ACGME COMPETENCIES
Medical Knowledge
Patient Care
SUCCESSFUL COMPLETION REQUIREMENTS
Successful completion of this educational activity requires the learner to:
· View a course overview page, containing all CME and disclosure information, including acknowledgement of commercial support and disclosure of unlabeled use, prior to the start of each module.
· Complete a 10-question pre-exam prior to each module. Learners should note any pre-exam questions answered incorrectly for clarification during module study.
· Be given the option of downloading a printed syllabus containing the presentation and narrative.
· Participate in the interactive activity: Audio narration is synchronized with PowerPoint presentation that can be advanced, stopped or reversed as desired.
· Complete a 10-question post-exam after each module, with feedback of correct/incorrect answers, scoring a minimum of 70% in two attempts.
· Complete the evaluation survey.
· Print certificate of completion.
DISCLOSURES FOR PLANNERS AND FACULTY
Planners
Susan Gitlin, PhD: Ownership/Stock: Merck; Walgreen Company
Andrew R. La Barbera, PhD: Nothing to Disclose
Richard H. Reindollar, MD: Nothing to Disclose
Nancy Bowers, BSN, RN, MPH: Nothing to Disclose
Content Developers and Reviewers
· Morgan Amick, BS: Nothing to Disclose
· Anthony Anderson, DSc: Nothing to Disclose
· Marlane Angle, PhD: Consultant: Previvo
· C. Brent Barrett, PhD: Consultant: ReproSource Fertility Diagnostics
· Charles Bormann, PhD: Nothing to Disclose
· Bruce Carr, MD: Grant/Research: AbbVie, Medicines 360; Speakers Bureau: Shionogi, Noven, Pfizer
· Marcelle Cedars, MD: Grant/Research: Nora Therapeutics; Ferring Pharmaceuticals
· Grace Centola, PhD: Consultant: New England Cryogenic Center; Cryos International-NY, Central Park Fertility
· Carli Chapman, MS: Nothing to Disclose
· Ri-Cheng Chian, PhD: Other: Cooper Surgical/SAGE Company
· Susan Crockin, JD: Consultant: BMS, Merck, Prometheus; Advisory Board: GSK, CoStim, Aveo; Speakers Bureau: Pfizer Canada, BMS
· Judith Daar, JD: Nothing to Disclose
· Erma Drobnis, PhD: Nothing to Disclose
· Kathryn Go, PhD: Nothing to Disclose
· Kay Graff, MS: Consultant: Steptoe Therapeutics; Employee: Pelton & Crane
· Elizabeth Grill, PsyD: SouthEastern Fertility: Speakers Bureau
· Shalini Gunawardena, RN, BSN: Walgreen's Nursing Advisory Board
· Lee Higdon, PhD: Nothing to Disclose
· Kristen Ivani, PhD: Nothing to Disclose
· Sangita Jindal, PhD: Nothing to Disclose
· Emily Jungheim, MD: Spouse is paid consultant: Abbvie, Genentech, Spectrum, Celgene; Speakers bureau: Genentech
· Levent Keskintepe, DVM, PhD: Nothing to Disclose
· Ann Kiessling, PhD: Nothing to Disclose
· Rebecca Krisher, PhD: Grant/Research: Serono
· Martin Langley, BS: Nothing to Disclose
· Michael Lee, MS: Consultant: Cook Medical
· Bruce Lessey, MD, PhD: Nothing to Disclose
· Dennis Matt, PhD: Nothing to Disclose
· David McCulloh, PhD: Consultant: Infertility and IVF Medical Associates of Western NY; ReproART; Biogenetics Corporation; Employee: NYU Langone Medical Center
· Peter McGovern, MD: Nothing to Disclose
· Yves Menezo, DSc, PhD: Consultant: Nurilia
· Z. Peter Nagy, MD, PhD: Direct stockholder: My Egg Bank; Paid consultant: Origio, Fertilitech; Speakers bureau: Merck MSD
· Mike Neal, MSc: Nothing to Disclose
· Fariba Nehchiri, MSc: Nothing to Disclose
· Sergio Oehninger, PhD: Nothing to Disclose
· Kimball Pomeroy, PhD: Nothing to Disclose
· Thomas (Rusty) Pool, PhD: Other: Auxogyn
· Marc Portmann, MHA, MT: Nothing to Disclose
· Catherine Racowsky, PhD: Consultant: Nora Therapeutics
· Michael Reed, PhD: Nothing to Disclose
· Lisa Rinehart, JD: Nothing to Disclose
· William Roudebush, PhD: Nothing to Disclose
· Denny Sakkas, PhD: Consultant: Good Start Genetics; Other: Fertilitech, Origio
· Mitchel Schiewe, PhD: Nothing to Disclose
· Ira Sharlip, MD: Consultant: Pfizer, Lilly, Absorption, Vyrix
· Scott Smith, PhD: Product Review: Biocoat
· Amy Sparks, PhD: Nothing to Disclose
· Laurel Stadtmauer, MD: Nothing to Disclose
· Jason Swain, PhD: Consultant: Irvine Scientific
· Tyl Taylor, MSc: Consultant; Spouse employed: Biodiseño
· Helen Tempest, PhD: Nothing to Disclose
· James Toner, MD, PhD: Speakers bureau: Merck
· Nathan Treff, PhD: Nothing to Disclose
· Tom Turner, MS: Nothing to Disclose
· Matthew VerMilyea, PhD: Consultant: Auxogyn, Irvine Scientific, Genea Biomedx
· Michael Vernon, PhD: Nothing to Disclose
· Diane Wright, PhD: Nothing to Disclose
· Hang Yin, PhD: Nothing to Disclose
It is the policy of the ASRM to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty/authors participating in this activity were required to disclose any relationships they may have with commercial entities whose products or services are used to treat patients so that participants may evaluate the objectivity of the presentations. The content and views presented in this activity are those of the faculty/authors and do not necessarily reflect those of the ASRM. Any discussion of off-label, experimental, or investigational use of drugs or devices will also be disclosed. The disclosure statements were reviewed by the Subcommittee for Standards of Commercial Support of the CME Committee of ASRM and any perceived conflicts of interest were resolved in accordance with the policies of the ACCME.
STATEMENT OF SUPPORT
No commercial support has been provided for this activity.